Health
India’s HIV infections are rising quietly. Why twice-yearly lenacapavir matters

What the report says
The Central Drugs Standard Control Organisation CDSCO has permitted two Indian drugmakers to make generic lenacapavir without local clinical trials amid a steady and worrying rise of new HIV infections in many states in the country
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Uganda Urged to Decriminalise Suicide as Advocates Push for Mental Health ReformNile Post
UCI Rebrands as Uganda Strengthens Capacity for Advanced Cancer CareNile Post
Parliamentary Health Committee Flags Staffing, Equipment Gaps in Busoga HospitalsNile Post
Rukungiri Health Workers Urged to Keep Professional Licences Up to DateNile Post